OR WAIT null SECS
April 08, 2020
The agency sent a warning letter to Genesis II Church for marketing fraudulent chlorine dioxide products the company claims treats and prevents COVID-19.
April 02, 2020
FDA is encouraging alternative insulins and challenging anticompetitive practices.
As the coronavirus pandemic unfolds, Pharma must practice science over hype.
Regulatory emergency planning has been put to the test with the COVID-19 pandemic.
April 01, 2020
With new tests showing NDMA levels increase under normal storage conditions, FDA calls for removal of ranitidine products from the market.
March 27, 2020
AstraZeneca has announced that it has achieved approval in Japan for Lokelma (sodium zirconium cyclosilicate) for the treatment of patients with hyperkalemia (elevated blood potassium levels).
March 25, 2020
In light of the current COVID-19 pandemic, the agencies co-chaired the first global regulators meeting to facilitate development of vaccines against SARS-CoV-2, which causes COVID-19.
March 24, 2020
FDA officials are rolling out guidance and support for researchers striving to assess potential treatments for COVID-19 while the agency tries to object to premature optimism and regain public credibility.
March 20, 2020
FDA is offering advice and added flexibility to help sponsors adjust ongoing and planned clinical research programs during the COVID-19 outbreak.
March 19, 2020
In a daily press briefing on March 18, 2020, the World Health Organization (WHO) announced that, along with its partners, it will be organizing a large international study that will compare various untested treatments for COVID-19.